Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

First anti-HIV dual CCR5/CXCR4 antagonist described / News in Context

Feb. 14, 2005

Novel anti-HIV agents developed by Lead Chemical researchers

Feb. 10, 2005

Excellent preclinical data on rilpivirine, an anti-HIV agent from Janssen

Feb. 10, 2005

Phase I program of tgAAC-09 for HIV/AIDS expands to India

Feb. 9, 2005

First phase III trial of an HIV vaccine shows no success in preventing infection

Feb. 8, 2005

HIV protease inhibitor PL-100 successfully completes viral crossresistance study

Feb. 8, 2005

ViroLogic signs service agreement to support GSK HIV drug development

Feb. 8, 2005

Preliminary 48-week data on efficacy and safety of tenofovir/emtricitabine regimen in HIV infection

Feb. 7, 2005

Deoxyhypusine synthase inhibition as a new strategy against HIV/News in Context

Jan. 28, 2005

Positive phase I/II results of AVR-118 in cachectic patients with AIDS

Jan. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...